Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma insulin concentrations such as those observed during the present insulin/glucose or glucose infusion studies, are known to completely suppress hepatic glucose production (27); thus, under these conditions, total glucose uptake is equal to exogenous glucose infusion.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [27]
In the citing paper
“Notably, insulin resistance is also associated with a decreased ability to suppress lipolysis in adipose tissue and altered fatty acid oxidation.50,51”
From The effects of sleep disruption on metabolism, hunger, and satiety, and the influence of psychosocial stress and exercise: A narrative review (2024) · cites this paper as [51]
In the citing paper
“In lean healthy individuals insulin stimulates glucose uptake into skeletal muscle in a dose-dependent manner, with a half-maximal effect (EC50) at a plasma insulin concentration ~60 μU/mL [21].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“Using the gold standard euglycemic hyperinsulinemic clamp technique to quantify insulin-stimulated glucose uptake, they demonstrated that both lean and obese T2DM subjects have marked decrease (>50%) in whole body glucose disposal during the insulin clamp.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“During the postabsorptive state, the plasma insulin concentration is low. Since the plasma insulin concentration is the principal factor that restrains lipolysis in adipocytes [21] and stimulates glucose uptake in skeletal muscle [21], during the fasting state, muscle glucose uptake is low and the plasma FFA concentration is elevated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“More than 20 years ago Randle and co-workers introduced the concept of substrate competition, whereby enhanced availability and oxidation of FFA leads to an impairment in glucose oxidation (17).”
BackgroundImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Since CPT I is inhibited by both insulin and malonyl-CoA, which is generated by condensation of acetyl-CoA (56), the insulin-mediated decline in FFA oxidation could have been due to a direct effect of the hormone on CPT I.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 2×
“in insulin-mediated glucose metabolism affects both hepatic and peripheral tissues, primarily muscle (1-6).”
BackgroundSelf-citationEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationRadioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Cited by
Items 401–500 of 812
KURIOKA, S., MURAKAMI, Y., NISHIKI, M., SOHMIYA, M., KOSHIMURA, K., & KATO, Y. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.459 · Cited by 35
DeFronzo, R. A., Mehta, R. J., & Schnure, J. J. (2013) · Hospital Practice · doi:10.3810/hp.2013.04.1062 · Cited by 39
Self-citationPioglitazone increases non-esterified fatty acid clearance in upper body obesity
Shadid, S., & Jensen, M. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0051-0 · Cited by 39
Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDM
Groop, L. C., Widén, E., Ekstrand, A., Saloranta, C., Franssila-Kallunki, A., Schalin-Jäntti, C., & Eriksson, J. G. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.831 · Cited by 35
“In contrast, the insulin concentration for half-maximal suppression of hepatic glucose production is in the range of 10-15 jJiU/ml (11,12).”
BackgroundSelf-citationElliott, T. G., & Viberti, G. C. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80246-0 · Cited by 41
Influence of endogenous NEFA on beta cell function in humans
Rebelos, E., Seghieri, M., Natali, A., Balkau, B., Golay, A., Piatti, P. M., Lalic, N. M., Laakso, M., Mari, A., & Ferrannini, E. (2015) · Diabetologia · doi:10.1007/s00125-015-3685-6 · Cited by 39
Self-citationHo, G. T. T., Kase, E. T., Wangensteen, H., & Barsett, H. (2017) · Molecules · doi:10.3390/molecules22010090 · Cited by 34
“The skeletal muscle and the liver play an important role in blood glucose control, storage and utilization of glucose [9].”
BackgroundCirculating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes
Sylow, L., Vind, B. F., Kruse, R., Møller, P. M., Wojtaszewski, J. F. P., Richter, E. A., & Højlund, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa090 · Cited by 36
Li, A., Mei, Y., Zhao, M., Xu, J., Seery, S., Li, R., Zhao, J., Zhou, Q., Ge, X., & Xu, Q. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143308 · Cited by 36
Reproducibility and discrimination of different indices of insulin sensitivity and insulin secretion
Hudak, S., Huber, P., Lamprinou, A., Fritsche, L., Stefan, N., Peter, A., Birkenfeld, A. L., Fritsche, A., Heni, M., & Wagner, R. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258476 · Cited by 34
Gelding, S. V., Coldham, N., Niththyananthan, R., Anyaoku, V., & Johnston, D. G. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb02065.x · Cited by 34
Toft, I., Bønaa, K. H., Lindal, S., & Jenssen, T. G. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90125-1 · Cited by 40
Lanzi, R., Manzoni, M. F., Andreotti, A. C., Malighetti, M. E., Bianchi, E., Sereni, L. P., Caumo, A., Luzi, L., & Pontiroli, A. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2239 · Cited by 33
“Insulin infusion was started at 1200 h to obtain steady-state insulin levels and a significant decrease in plasma FFA levels by the time of GHRH injection (1300 h), as indicated by a prior pilot study and according to previous reports (28).”
MethodGlucose oxidation after a peritoneal and an oral glucose load in dialyzed patients
Delarue, J., Maingourd, C., Lamisse, F., Garrigue, M. A., Bagros, P., & Couet, C. (1994) · Kidney International · doi:10.1038/ki.1994.152 · Cited by 33
Ebeling, P. R., & Koivisto, V. A. (1994) · Diabetologia · doi:10.1007/s001250050094 · Cited by 33
“Similar associations have previously been shown both in healthy subjects during Intralipid infusion [29, 33-35] and in Type 2 diabetic patients with elevated NEFA concentrations [8, 35].”
BackgroundResultKatz, H., Butler, P., Homan, M., Zerman, A., Caumo, A., Cobelli, C., & Rizza, R. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.4.e561 · Cited by 33
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
Wong, R., Lam, E., Bramante, C. T., Johnson, S., Reusch, J. E. B., Wilkins, K. J., & Yeh, H. (2023) · Current Diabetes Reports · doi:10.1007/s11892-023-01515-1 · Cited by 39
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
Hanefeld, M., & Bramlage, P. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0366-z · Cited by 36
“The resulting hyperglycemia and the increase of free fatty acids cause a further loss of β-cell function and increased apoptosis (gluco- and lipotoxicity) [20, 21].”
BackgroundSolis‐Herrera, C., Daniele, G., Alatrach, M., Agyin, C., Triplitt, C. L., Adams, J. M., Patel, R., Gastaldelli, A., Honka, H., Chen, X., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2177 · Cited by 32
Self-citationTumor Necrosis Factor Receptor-1 Can Function through a Gαq/11-β-Arrestin-1 Signaling Complex
Kawamata, Y., Imamura, T., Babendure, J. L., Lu, J. C., Yoshizaki, T., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705869200 · Cited by 32
Hoenig, M. E., Thomaseth, K., Waldron, M. K., & Ferguson, D. C. (2006) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2006.04.003 · Cited by 36
“increased gluconeogenesis, and perturbed lipid metabolism [30–33].”
POWRIE, J. K., SMITH, G. D., HENNESSY, T. R., SHOJAEE‐MORADIE, F., KELLY, J. M., SÖNKSEN, P. H., & JONES, R. H. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01458.x · Cited by 32
Bruce, R., Godsland, I., Walton, C., Crook, D., & Wynn, V. (1994) · Metabolism · doi:10.1016/0026-0495(94)90222-4 · Cited by 32
Watanabe, T., Tamura, Y., Kakehi, S., Funayama, T., Gastaldelli, A., Takeno, K., Kawaguchi, M., Yamamoto, R., Sato, F., Ikeda, S., et al. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12262 · Cited by 31
Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions
Swe, M. T., Pongchaidecha, A., Chatsudthipong, V., Chattipakorn, N., & Lungkaphin, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27598 · Cited by 38
“Insulin deficiency or insulin resistance in the diabetic condition accelerates lipolysis and releases free fatty acids and glycerol into the circulation indicating adipose tissue as being a potential source for increased substrate supply for gluconeogenesis (Groop et al., 1989).”
BackgroundYang, L., Liang, H., Liu, X., Wang, X., Cheng, Y., Zhao, Y., Liu, L., Huang, G., Wang, X., & Zhou, Z. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab026 · Cited by 32
“In addition, M/log I ratio (ie, the ratio of M divided by the natural logarithmical insulin concentration in steady state) was also included to assess insulin sensitivity since the effects of insulin on glucose uptake increase in a logarithmical manner (19, 20).”
MethodWagner, R. J., Fritsche, L., Heni, M., Fehlert, E., Stefan, N., Staiger, H., Häring, H., & Fritsche, A. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0930-5 · Cited by 35
Utzschneider, K. M., Largajolli, A., Bertoldo, A., Marcovina, S., Nelson, J. E., Yeh, M. M., Kowdley, K. V., & Kahn, S. E. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.11.007 · Cited by 36
“Hepatic insulin sensitivity was determined as: (1) the hepatic insulin resistance index (HIR index: basal EGP × fasting plasma insulin) (Groop et al., 1989) and (2) percent suppression of EGP at the end of the low dose insulin clamp.”
MethodInsulin resistance, adipose depots and gut: Interactions and pathological implications
Gastaldelli, A., Natali, A., Vettor, R., & Corradini, S. G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.013 · Cited by 46
“The logic behind this calculation s as follows: (1) under basal conditions, themajority (∼85–90%) of GP is derived from liver [26]; and (2) insulin is a potent inhibitor f HGP: even very small increments in the ambient insulin conentration exert a potent inhibitory effect on HGP [17].”
BackgroundInfluentialLin, R.-T., Pai, H.-C., Lee, Y., Tzeng, C., Chang, C.-H., Hung, P., Chen, Y., Hsu, T., Tsai, C.-C., Lin, J., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/969824 · Cited by 33
“These results are compatible with other studies showing that in early type 2 diabetics, the ability of insulin to inhibit lipolysis and to reduce the plasma FFA concentration ismarkedly impaired [31].”
BackgroundResultInfluentialCespiati, A., Meroni, M., Lombardi, R., Oberti, G., Dongiovanni, P., & Fracanzani, A. L. (2022) · Biomedicines · doi:10.3390/biomedicines10010182 · Cited by 33
“In muscle tissue, insulin promotes the storage of postprandial glucose through the phosphorylation of several target proteins involved in glycogen synthesis and in the translocation of glucose transporter type 4 (GLUT4) on the plasma membrane [56].”
BackgroundMalin, S. K., Kashyap, S., Hammel, J. P., Miyazaki, Y., DeFronzo, R. A., & Kirwan, J. P. (2014) · Diabetes Care · doi:10.2337/dc13-3011 · Cited by 32
“the product of the basal rate of FFA turnover and the fasting insulin concentration (12,13).”
BackgroundMethodSelf-citationFerri, C., Laurenti, O., BELLINI, C., Cassone-Faldetta, M., Properzi, G., Santucci, A., & DEMATTIA, G. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00180-j · Cited by 30
Alterations of Glucose Metabolism in Type 2 Diabetes Mellitus. An Overview
Bonadonna, R. C. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021429.89218.c6 · Cited by 30
“Insulin dose-response curve of endogenous glucose production in controls and in patients with type 2 diabetes [3].”
BackgroundInfluentialSelf-citationEarly disturbances in insulin secretion in the development of type 2 diabetes mellitus
van Haeften, T. W. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00267-8 · Cited by 41
“In diabetic subjects, hepatic glucose production is less reduced after a meal than in non-diabetic controls, which (also) points to insulin resistance, and which is responsible for the post-prandial rise in plasma glucose level (Groop et al., 1989; Gerich, 1993).”
Matching treatment to pathophysiology in type 2 diabetes
Gerich, J. E. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80017-5 · Cited by 38
Wang, X., Patterson, B. W., Smith, G. I., Kampelman, J., Reeds, D. N., Sullivan, S. A., & Mittendorfer, B. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01364.2012 · Cited by 29
Kawamori, R., Morishima, T., Ikeda, M., Kubota, M., Kubota, M., Kishimoto, M., Shiba, Y., Matsuhisa, M., Kodama, M., Watarai, T., et al. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90099-x · Cited by 31
Diabetic Cardiovascular Disease: Getting to the Heart of the Matter
Peterson, L. R., McKenzie, C. R., & Schaffer, J. E. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9374-7 · Cited by 33
Sarafidis, P. A., & Bakris, G. L. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2005.04679.x · Cited by 32
Miya, A., Nakamura, A., Miyoshi, H., Takano, Y., Sunagoya, K., Hayasaka, K., Shimizu, C., Terauchi, Y., & Atsumi, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00081 · Cited by 32
“FFA is mobilized from triglycerides, stored in adipose tissue through the process of lipolysis (13).”
BackgroundLow density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes
Phillips, C. M., Owens, D., Collins, P. B., & TOMKIN, G. H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.033 · Cited by 32
Baba, T., & Neugebauer, S. (1994) · Drugs · doi:10.2165/00003495-199447030-00002 · Cited by 35
Merovci, A., Finley, B., HANSIS-DIARTE, A. A., Neppala, S., Abdul‐Ghani, M. A., Cersósimo, E., Triplitt, C. L., & DeFronzo, R. A. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004199 · Cited by 41
Self-citationGaetano, A. D., & Hardy, T. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222833 · Cited by 31
“This relationship is supported by experimental observations [46, 47].”
ResultIn search of the ideal treatment for migraine headache
Bic, Z., Blix, G., Hopp, H. P., & Leslie, F. M. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90170-0 · Cited by 27
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients
Prato, S. D., Riccio, A., de Kreutzenberg, S. V., Dorella, M., Avogaro, A., Marescotti, M. C., & Tiengo, A. (1993) · Metabolism · doi:10.1016/0026-0495(93)90167-m · Cited by 28
Triplitt, C. L., Glass, L. C., Miyazaki, Y., Wajcberg, E., Gastaldelli, A., Filippis, E. D., Cersósimo, E., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-0564 · Cited by 29
Self-citationAbbasi, F., McLaughlin, T., Lamendola, C. A., & Raven, G. M. (2000) · Metabolism · doi:10.1016/s0026-0495(00)91065-5 · Cited by 27
Vidal, H., Langin, D., Andréelli, F., Millet, L., Larrouy, D., & Laville, M. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e830 · Cited by 38
Schneider, D. J., & Sobel, B. E. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200506 · Cited by 29
Physiological responses to maximal eating in men
Hengist, A., Edinburgh, R. M., Davies, R. G., Walhin, J., Buniam, J., James, L. J., Rogers, P. J., Gonzalez, J. T., & Betts, J. A. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001270 · Cited by 27
“Increasing insulinaemia across the ranges observed in the present study dosedependently increases peripheral glucose disposal rates(15).”
BackgroundKawaguchi, M., Tamura, Y., Kakehi, S., Takeno, K., Sakurai, Y., Watanabe, T., Funayama, T., Sato, F., Ikeda, S., Ogura, Y., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1896 · Cited by 28
Yoshida, A., Matsubayashi, Y., Nojima, T., Suganami, H., Abe, T., Ishizawa, M., Fujihara, K., Tanaka, S., Kaku, K., & Sone, H. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02254 · Cited by 31
Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance
Berrish, T. S., Hetherington, C., Alberti, K. G. M. M., & Walker, M. (1995) · Diabetologia · doi:10.1007/bf00401842 · Cited by 26
Yoshikawa, T., Noguchi, Y., Doi, C., Makino, T., Okamoto, T., & Matsumoto, A. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00086-5 · Cited by 29
Bajaj, M. S., Berria, R., Pratipanawatr, T., Kashyap, S. R., Pratipanawatr, W., Belfort, R., Cusi, K. J., Mandarino, L. J., & DeFronzo, R. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2001 · Cited by 30
“Obese nondiabetic individuals, the offspring of parents with type 2 diabetes mellitus, individuals with impaired glucose tolerance, and type 2 diabetic patients are characterized by insulin resistance, accelerated rates of lipolysis (10, 20, 21, 34), and day-long increased plasma free fatty acid (FFA) levels (34).”
BackgroundMethodSelf-citationEffect of lipid oxidation on glucose utilization in humans
Jéquier, E. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.527s · Cited by 25
Suppression of non-esterified fatty acids to treat type A insulin resistance syndrome
Kumar, S., Durrington, P. N., Bhatnagar, D., & Laing, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90184-8 · Cited by 26
Drugs on the Horizon for Treatment of Type 2 Diabetes
Rachman, J., & Turner, R. C. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00526.x · Cited by 30
Effect of glycemia and nonesterified fatty acids on forearm glucose uptake in normal humans
Walker, M., Fulcher, G. R., Sum, C. F., Ørskov, H., & Alberti, K. G. M. M. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.3.e304 · Cited by 28
Insulin resistance in non-insulin-dependent diabetes mellitus
Alzaid, A. (1996) · Acta Diabetologica · doi:10.1007/bf00569416 · Cited by 28
Mackay, P., Ynddal, L., Andersen, J. V., & McCormack, J. G. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00293.x · Cited by 25
Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance
Cree‐Green, M., Wiromrat, P., Stuppy, J. J., Thurston, J. E., Bergman, B. C., Baumgartner, A., Bacon, S. D., Scherzinger, A. L., Pyle, L. L., & Nadeau, K. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2018 · Cited by 27
“A high-dose hyperinsulinemic-euglycemic clamp (HE-clamp) is the most common procedure to assess peripheral IR, and this has been performed in both adults and youth (2, 11, 13, 18, 20, 21, 28, 35).”
BackgroundMethodMagnan, C., Gilbert, M., & Kahn, B. B. (1996) · Lipids · doi:10.1007/bf02524288 · Cited by 25
“In vivo studies have shown that the rates of FFA/lipid oxidation are positively correlated with the rate of hepatic glucose production (18).”
BackgroundInsulin Resistance in Type 2 Diabetes
Yki‐Järvinen, H. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch11 · Cited by 32
Tamura, Y. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0435 · Cited by 26
“If glucose clamp is performed without a glucose tracer but with a high insulin infusion rate (~100 mU/m2 per min), the glucose infusion rate (GIR) to maintain euglycemia indicates peripheral glucose uptake, because EGP is completely suppressed by insulin [11].”
BackgroundObstructive Sleep Apnea Is Associated With Altered Glycemic Patterns in Pregnant Women With Obesity
Farabi, S. S., Barbour, L. A., HEISS, K. P., Hirsch, N. M., DUNN, E. Z., & Hernandez, T. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00159 · Cited by 26
Glycation Alters the Fatty Acid Binding Capacity of Human Serum Albumin
Henning, C., Stübner, C. A., Arabi, S. H., Reichenwallner, J., Hinderberger, D., Fiedler, R., Girndt, M., Sanzo, S. D., Ori, A., & Glomb, M. A. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07218 · Cited by 24
Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review
DeFronzo, R. A., & Auchus, R. J. (2025) · Diabetes · doi:10.2337/db25-0120 · Cited by 34
Self-citationWhat are the pharmacotherapy options for treating prediabetes?
Daniele, G., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944160 · Cited by 27
“1 Insulin resistance Insulin resistance is a core defect in both prediabetes and T2DM [13-15,24,33,37-43], involves liver [13-15,41,43], muscle [13-15,40,42,43] and adipose tissue [15], and precedes the development of glucose intolerance and overt T2DM (Figure 1) [13-15,24,26,34,35,44,45].”
BackgroundSelf-citationGLUT4 Gene Polymorphisms and Their Association with Type 2 Diabetes in South Indians
Bodhini, D., Radha, V., Ghosh, S., Majumder, P. P., Rao, M. R. S., & Mohan, V. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0219 · Cited by 25
Stümvoll, M., Wahl, H. G., Machicao, F., & Häring, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0793-x · Cited by 23
“Previous studies have shown a correlation between glucose and lipid oxidation in normal [21] and diabetic subjects [10] and also between insulin’s glucoregulatory and antilipolytic effect based on NEFA concentrations [22].”
BackgroundAdipose tissue metabolism, diabetes and vascular disease — lessons from in vivo studies
Summers, L. K. M. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.001 · Cited by 29
Heterogeneity in limb fatty acid kinetics in type 2 diabetes
Sacchetti, M., Olsen, D. B., Saltin, B., & van Hall, G. (2005) · Diabetologia · doi:10.1007/s00125-005-1727-1 · Cited by 24
“Type 2 diabetes has been shown to be associated with impaired suppression of fatty acid levels and fatty acid Ra by insulin [24, 25].”
BackgroundGlucose and fat metabolism in adults with growth hormone deficiency
Salomon, F., Cuneo, R. C., Umpleby, A. M., & Sönksen, P. H. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02551.x · Cited by 24
“Furthermore, glucose oxidation represented only 47% of glucose turnover, a value below the normal range of 65-89% reported in normal subjects (Mandarin0 et al., 1987; Groop et al., 1989; 1991; Thorburn et al., 1990).”
BackgroundReversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man
Ekstrand, A., Saloranta, C., Ahonen, J. P., Grönhagen‐Riska, C., & Groop, L. (1992) · Metabolism · doi:10.1016/0026-0495(92)90306-u · Cited by 22
Self-citationBush, N. C., Basu, R., Rizza, R. A., Nair, K. S., Khosla, S., & Jensen, M. D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2285 · Cited by 22
Wallenius, K., Kjellstedt, A., Thalén, P., Löfgren, L., & Oakes, N. D. (2013) · PPAR Research · doi:10.1155/2013/305347 · Cited by 22
Insulin Action, Glucose Homeostasis and Free Fatty Acid Metabolism: Insights From a Novel Model
Stefanovski, D., Punjabi, N. M., Boston, R. C., & Watanabe, R. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.625701 · Cited by 28
“In individuals with obesity or type 2 diabetes suffer from insulin resistance, a state where insulin is inefficient in performing the above outlined roles (1).”
BackgroundEffect of Calorie Restriction and Exercise on Type 2 Diabetes
Shakoor, H. I., Apostolopoulos, V., Feehan, J., Ali, H. I., Ismail, L. C., Dhaheri, A. S. A., & Stojanovska, L. (2021) · PRILOZI · doi:10.2478/prilozi-2021-0010 · Cited by 36
“Additionally, insulin is a powerful inhibitor of lipolysis; even mild elevations of insulin in the plasma cause a remarkable reduction in free fatty acid levels [11].”
BackgroundTherapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection
Bielka, W., Przezak, A., & Pawlik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147605 · Cited by 23
“In patients with a severe course of COVID-19, viral-induced inflammation may affect the functions of the skeletal muscle and liver, which are the major organs responsible for insulin-mediated glucose uptake, thereby increasing insulin resistance [10].”
BackgroundLiver or kidney: Who has the oar in the gluconeogenesis boat and when?
Sahoo, B., Srivastava, M., Katiyar, A., ECELBARGER, C. A., & Tiwari, S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.1049 · Cited by 27
Luong, T. V., Pedersen, M. G. B., Abild, C. B., Lauritsen, K. M., Kjærulff, M. L. G., Møller, N., Gormsen, L. C., & Søndergaard, E. (2024) · Diabetes · doi:10.2337/db24-0162 · Cited by 25
Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia
Carpentier, A. C., Labbé, S. M., Grenier–Larouche, T., & Noll, C. (2011) · Clinical Lipidology · doi:10.2217/clp.11.60 · Cited by 26
Singh, B. M., Krentz, A., & Nattrass, M. (1993) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(93)90023-x · Cited by 21
Daytime variations in glucose tolerance in people with impaired glucose tolerance
Santos, M. L., Aragon, F. F., Padovani, C. R., & Pimenta, W. P. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.007 · Cited by 25
Regulation of Intermediary Metabolism During Fasting and Feeding
DeFronzo, R. A., & Ferrannini, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00035-4 · Cited by 26
Self-citationWalker, M., Agius, L., Ørskov, H., & Alberti, K. G. M. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90219-e · Cited by 23
Prato, S. D., de Kreutzenberg, S. V., Riccio, A., Maifreni, L., Duner, E., LISATO, G., Iavicoli, M., & Tiengo, A. (1990) · Diabetologia · doi:10.1007/bf00400571 · Cited by 24
“[41] have recently shown that a rise in plasma insulin concentration comparable to that observed in the post-wandial phase in our patients can induce a 50% inhibition of HGP without promoting peripheral glucose disposal.”
Background2 Hepatic glucose metabolism and insulin resistance in NIDDM and obesity
Barrett, E. J., & Liu, Z. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80238-1 · Cited by 23
Darwish, R., Alcibahy, Y., Bucheeri, S., Albishtawi, A., Tama, M., Shetty, J. K., & Butler, A. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313169 · Cited by 31
“IR is mainly present in the muscle and the liver [30–32], though it is also present in other organs, such as adipose tissue [33,34], the gastrointestinal tract [35], and kidneys [36].”
Gonzalez, J. T., Dirks, M. L., Holwerda, A. M., Kouw, I. W. K., & van Loon, L. J. C. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04431-4 · Cited by 22
Effect of NAD on PARP-mediated insulin sensitivity in oleic acid treated hepatocytes
Pang, J., Cui, J., Gong, H., Xi, C., & Zhang, T. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24907 · Cited by 20
Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity
Muniyappa, R., Noureldin, R., Ouwerkerk, R., Liu, E. Y., Madan, R., Abel, B. S., Mullins, K. P., Walter, M. F., Skarulis, M. C., & Gharib, A. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1139 · Cited by 21
Altered skeletal muscle glucose transport and blood lipid levels in habitual cigarette smokers
Rincón, Krook, A., Galuska, Wallberg‐Henriksson, H., & Zierath, J. R. (1999) · Clinical Physiology · doi:10.1046/j.1365-2281.1999.00161.x · Cited by 24
Bahijri, S., Alissa, E. M., Akbar, D. H., & Ghabrah, T. (2010) · Annals of Saudi Medicine · doi:10.4103/0256-4947.65252 · Cited by 22
Effects of one single bout of low-intensity exercise on postprandial lipaemia in type 2 diabetic men
Dalgaard, M., Thomsen, C., & Hermansen, K. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20041227 · Cited by 26
“In lean type 2 diabetic patients (Groop et al. 1989), impairment of both the insulin suppression of NEFA and the turnover of NEFA was found as compared with ageand weight-matched controls.”
ResultCombined Insulin-Sulfonylurea Therapy in Treatment of NIDDM
Groop, L., Groop, P., & Stenman, S. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.47 · Cited by 22
“An increase in the plasma insulin concentration of 10 pM reduces hepatic glucose production by 50% (44,45), which in turn should result in significant lowering of fasting plasma glucose.”
BackgroundSelf-citationWagner, R. J., Fritsche, L., Heni, M., Fehlert, E., Stefan, N., Staiger, H., Häring, H., & Fritsche, A. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1002-1 · Cited by 21
Metadata
- Authors
- Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- University of Helsinki (FI)
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 205-213
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303971
- OpenAlex
- W1981456793
- Cited by
- 812
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 28 · 2023: 15 · 2022: 27 · 2021: 30 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 32 · 2016: 26 · 2015: 22 · 2014: 22 · 2013: 26 · 2012: 26
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- Fogarty International Center (F05-TWO-3451)
- National Center for Research Resources (RR 125)
- Ministero dell'Istruzione e del Merito
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- type 2 diabetes, insulin resistance, glucose metabolism, free fatty acid metabolism, hepatic glucose production, glucose oxidation, nonoxidative glucose metabolism, fatty acid oxidation, fatty acid re-esterification, hyperinsulinemia, insulin clamp, lipid oxidation
- MeSH terms
- Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Oxidation-Reduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.